L. Martinez-gamboa, H. Brezinschek, G. Burmester, and T. Dorner, Immunopathologic role of B lymphocytes in rheumatoid arthritis: Rationale of B cell-directed therapy, Autoimmunity Reviews, vol.5, issue.7, pp.437-442, 2006.
DOI : 10.1016/j.autrev.2006.02.004

O. Neill, S. Glant, T. Finnegan, and A. , The role of B cells in animal models of rheumatoid arthritis, Frontiers in Bioscience, vol.12, issue.1, pp.1722-1736, 2007.
DOI : 10.2741/2184

P. Youinou, C. Jamin, and A. Saraux, B-cell: a logical target for treatment of rheumatoid arthritis, Clin Exp Rheumatol, vol.25, pp.318-328, 2007.

R. Eisenberg and D. Albert, B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus, Nature Clinical Practice Rheumatology, vol.104, issue.1, pp.20-27, 2006.
DOI : 10.1038/ncprheum0042

S. Rantapaa-dahlqvist, B. De-jong, E. Berglin, G. Hallmans, G. Wadell et al., Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis, Arthritis & Rheumatism, vol.4, issue.10, pp.2741-2749, 2003.
DOI : 10.1002/art.11223

M. Nielen, D. Van-schaardenburg, H. Reesink, R. Stadt, . Van-de et al., Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors, Arthritis & Rheumatism, vol.44, issue.2, pp.380-386, 2004.
DOI : 10.1002/art.20018

N. Talal, H. Grey, N. Zvaifler, J. Michalski, and T. Daniels, Elevated salivary and synovial fluid beta2-microglobulin in Sjogren's syndrome and rheumatoid arthritis, Science, vol.187, issue.4182, pp.1196-1198, 1975.
DOI : 10.1126/science.46621

K. Aho, M. Heliovaara, P. Knekt, A. Reunanen, A. Aromaa et al., Serum immunoglobulins and the risk of rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.56, issue.6, pp.351-356, 1997.
DOI : 10.1136/ard.56.6.351

J. Gottenberg, F. Aucouturier, J. Goetz, C. Sordet, I. Jahn et al., Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.66, issue.1, pp.23-27, 2007.
DOI : 10.1136/ard.2006.052159

F. Mackay, P. Schneider, P. Rennert, and J. Browning, APRIL: A Tutorial on B Cell Survival, Annual Review of Immunology, vol.21, issue.1, pp.231-264, 2003.
DOI : 10.1146/annurev.immunol.21.120601.141152

B. Combe, J. Benessiano, F. Berenbaum, A. Cantagrel, J. Daures et al., The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007.
DOI : 10.1016/j.jbspin.2007.06.001

F. Emmerich, G. Bal, A. Barakat, J. Milz, C. Muhle et al., High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura, British Journal of Haematology, vol.166, issue.2, pp.309-314, 2007.
DOI : 10.1126/science.1061965

J. Gottenberg, J. Sellam, M. Ittah, F. Lavie, A. Proust et al., No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjogren's syndrome, Arthritis Research & Therapy, vol.8, issue.1, p.30, 2006.
DOI : 10.1186/ar1884

A. Novak, D. Grote, S. Ziesmer, M. Kline, M. Manske et al., Elevated Serum B-Lymphocyte Stimulator Levels in Patients With Familial Lymphoproliferative Disorders, Journal of Clinical Oncology, vol.24, issue.6, pp.983-987, 2006.
DOI : 10.1200/JCO.2005.02.7938

V. Devauchelle-pensec, T. Josseaume, I. Samjee, M. Dougados, B. Combe et al., Ability of oblique foot radiographs to detect erosions in early arthritis: Results in the ESPOIR cohort, Arthritis & Rheumatism, vol.30, issue.12, pp.1729-1734, 2008.
DOI : 10.1002/art.24310

URL : https://hal.archives-ouvertes.fr/hal-00728204

F. Lavie, C. Miceli-richard, M. Ittah, J. Sellam, J. Gottenberg et al., Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production, Annals of the Rheumatic Diseases, vol.66, issue.5, pp.700-703, 2007.
DOI : 10.1136/ard.2006.060772

T. Vallerskog, M. Heimburger, I. Gunnarsson, W. Zhou, M. Wahren-herlenius et al., Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis, Arthritis Research & Therapy, vol.8, issue.6, p.167, 2006.
DOI : 10.1186/ar2076

A. Saraux, J. Berthelot, G. Chales, L. Henaff, C. Thorel et al., Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later, Arthritis & Rheumatism, vol.42, issue.11, pp.2485-2491, 2001.
DOI : 10.1002/1529-0131(200111)44:11<2485::AID-ART428>3.0.CO;2-S

A. Helm-van-mil, . Van-der, S. Le-cessie, H. Van-dongen, F. Breedveld et al., A prediction rule for disease outcome in patients with Recent-onset undifferentiated arthritis: How to guide individual treatment decisions, Arthritis & Rheumatism, vol.52, issue.2, pp.433-440, 2007.
DOI : 10.1002/art.22380

D. Symmons and A. Silman, Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register, Arthritis Research & Therapy, vol.8, issue.4, p.214, 2006.
DOI : 10.1186/ar1979

E. Berglin, T. Johansson, U. Sundin, E. Jidell, G. Wadell et al., Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset, Annals of the Rheumatic Diseases, vol.65, issue.4, pp.453-458, 2006.
DOI : 10.1136/ard.2005.041376

K. Forslind, M. Ahlmén, K. Eberhardt, I. Hafström, B. Svensson et al., Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP), Annals of the Rheumatic Diseases, vol.63, issue.9, pp.1090-1095, 2004.
DOI : 10.1136/ard.2003.014233

J. Katzmann, R. Clark, R. Abraham, S. Bryant, J. Lymp et al., Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains, Clin Chem, vol.48, pp.1437-1444, 2002.

A. Kawasaki, N. Tsuchiya, T. Fukazawa, H. Hashimoto, and K. Tokunaga, Presence of four major haplotypes in human BCMA gene: lack of association with systemic lupus erythematosus and rheumatoid arthritis, Genes and Immunity, vol.2, issue.5, pp.276-279, 2001.
DOI : 10.1038/sj.gene.6363770

G. Cheema, V. Roschke, D. Hilbert, and W. Stohl, Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases, Arthritis & Rheumatism, vol.275, issue.6, pp.1313-1319, 2001.
DOI : 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S

C. Collins, A. Gavin, T. Migone, D. Hilbert, D. Nemazee et al., B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels, Arthritis Research & Therapy, vol.8, issue.1, p.6, 2006.
DOI : 10.1186/ar1855

S. Tan, D. Xu, V. Roschke, J. Perry, D. Arkfeld et al., Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis, Arthritis & Rheumatism, vol.48, issue.4, pp.982-992, 2003.
DOI : 10.1002/art.10860

S. Bosello, P. Youinou, C. Daridon, B. Tolusso, B. Bendaoud et al., Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis, J Rheumatol, vol.35, pp.1256-1264, 2008.

K. Raza, F. Falciani, S. Curnow, E. Ross, C. Lee et al., Salmon M: Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin, Arthritis Research & Therapy, vol.7, issue.4, pp.784-795, 2005.
DOI : 10.1186/ar1733

W. Xu, B. He, A. Chiu, A. Chadburn, M. Shan et al., Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI, Nature Immunology, vol.173, issue.3, pp.294-303, 2007.
DOI : 10.1038/414660a

M. Li, Y. Wan, S. Sanjabi, A. Robertson, and R. Flavell, TRANSFORMING GROWTH FACTOR-?? REGULATION OF IMMUNE RESPONSES, Annual Review of Immunology, vol.24, issue.1, pp.99-146, 2006.
DOI : 10.1146/annurev.immunol.24.021605.090737

T. Seyler, Y. Park, S. Takemura, R. Bram, P. Kurtin et al., BLyS and APRIL in rheumatoid arthritis, Journal of Clinical Investigation, vol.115, issue.11, pp.3083-3092, 2005.
DOI : 10.1172/JCI25265